Bahrain Approves China’s Sinopharm Covid-19 Vaccine – BloombergQuint

(Bloomberg) — Bahrain approved the registration of the Sinopharm Group Co Ltd. vaccine against the coronavirus, about a week after the United Arab Emirates registered the Chinese-made vaccine.
Results from Phase III clinical trials showed an 86% efficacy rate, a 99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of Covid-19, the National Health Regulatory Authority said in a statement Sunday. Bahrains findings are based on data from more…

Click here to view the original article.